Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Percivale

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Clinical Oncology|June 1, 1991
A phase I study of recombinant interleukin-2 intraperitoneal infusion in patients with neoplastic ascites: toxic effects and immunologic resultsG Melioli, M R Sertoli, M Bruzzone, et al.
International Journal of Cancer|February 15, 1989
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2)G Melioli, E Baldini, M C Mingari, et al.
Anticancer Research|May 6, 1998
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancerM T Nobile, M C Barzacch, O Sanguineti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Clinical Oncology|June 1, 1991
A phase I study of recombinant interleukin-2 intraperitoneal infusion in patients with neoplastic ascites: toxic effects and immunologic resultsG Melioli, M R Sertoli, M Bruzzone, et al.
International Journal of Cancer|February 15, 1989
Phenotypic and functional characteristics of tumor-associated lymphocytes in patients with malignant ascites receiving intraperitoneal infusions of recombinant interleukin-2 (rIL-2)G Melioli, E Baldini, M C Mingari, et al.
Anticancer Research|May 6, 1998
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancerM T Nobile, M C Barzacch, O Sanguineti, et al.
Pageof 2